Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Actavis (Doryx brand)

M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of oral antibacterial drug to treat acne. The business unit offers drugs for the treatment of urethral or endocervical chlamydia infections.

Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Dublin
  • Ireland

Actavis (Doryx brand) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Actavis (Doryx brand)‘s full profile, request access.

Request full access to PitchBook

Actavis (Doryx brand) Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000 Formerly PE-Backed Lausanne, Switzerland 000000000000
To view this company’s complete list of competitors, request access »

Actavis (Doryx brand) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Actavis (Doryx brand)‘s full profile, request access.

Request full access to PitchBook